The role of guggulsterone on the NF-κB pathway in inflammatory bowel disease: preclinical evidence

被引:5
|
作者
Priya, S. K. Sujitha [1 ]
Jha, Ankita [1 ]
Satish Kumar, Rajappan Chandra [2 ]
Sabarathinam, Sarvesh [2 ]
机构
[1] SRM Inst Sci & Technol, Dept Pharm Practice, Kancheepuram 603203, Tamil Nadu, India
[2] SRM Inst Sci & Technol, Interdisciplinary Inst Indian Syst Med IIISM, Drug Testing Lab, Kattankulathur 603203, Tamil Nadu, India
来源
FUTURE SCIENCE OA | 2022年 / 8卷 / 06期
关键词
bioactive compounds; cytokines; dextran sodium sulfate; guggulsterone; inflammatory bowel disease; intestinal epithelial cells; NF-kappa B; preclinical studies; ulcerative colitis; INTESTINAL EPITHELIAL-CELLS; CYTOKINES; COLITIS;
D O I
10.2144/fsoa-2022-0020
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Guggulsterone, a phytosterol in the herb Commiphora wightii (Arn.) Bhandari, has been used in the treatment of diseases such as hyperlipidemia, arthritis and atherosclerosis. It has attracted significant research interest because of its pharmacological properties, especially its anti-inflammatory nature. It can be used for the treatment of inflammatory bowel disease (IBD), a disease characterized by chronic inflammation and damage in the gastrointestinal tract. In various preclinical studies, it inhibited NF-kappa B, an important pathway in the pathophysiology of IBD. This review summarizes the preclinical studies on this topic for providing more insights to the mechanism by which guggulsterone exerts its effect.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Role of NF-κB Pathway on Platelet Activation
    Schattner, Mirta
    CIRCULATION RESEARCH, 2013, 113 (09) : E92 - E92
  • [22] Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models
    Suri, Kanika
    Bubier, Jason A.
    Wiles, Michael, V
    Shultz, Leonard D.
    Amiji, Mansoor M.
    Hosur, Vishnu
    CELLS, 2021, 10 (09)
  • [23] Activation of NFκB in inflammatory bowel disease -: Reply
    Schreiber, S
    Nikolaus, S
    Hampe, J
    GUT, 1998, 43 (04) : 588 - 588
  • [24] Polyphenols mitigating inflammatory mechanisms in inflammatory bowel disease (IBD): focus on the NF-κB and JAK/STAT pathways
    Ismail, Elysha Nur
    Zakuan, Noraina
    Othman, Zulkefley
    Vidyadaran, Sharmili
    Mohammad, Hussin
    Ishak, Reezal
    INFLAMMOPHARMACOLOGY, 2024, : 759 - 765
  • [25] Altechromone A Ameliorates Inflammatory Bowel Disease by Inhibiting NF-κB and NLRP3 Pathways
    Li, Lei
    Huang, Jing
    Feng, Lixin
    Xu, Liyan
    Lin, Houwen
    Liu, Kechun
    Li, Xiaobin
    Wang, Rongchun
    MARINE DRUGS, 2024, 22 (09)
  • [26] Anti-inflammatory effect of miltirone on inflammatory bowel disease via TLR4/NF-κB/IQGAP2 signaling pathway
    Wang, Hongjian
    Gu, Junfei
    Hou, Xuefeng
    Chen, Juan
    Yang, Nan
    Liu, Ying
    Wang, Gang
    Du, Mei
    Qiu, Huihui
    Luo, Yi
    Jiang, Ziyu
    Feng, Liang
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 85 : 531 - 540
  • [27] Expression and significance of MT, NF-κB and HIF-1α in patients with inflammatory bowel disease
    Chuang, G.
    Baisui, F.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 226 - 226
  • [28] Ubiquitination regulation of inflammatory responses through NF-κB pathway
    Wu, Yunbing
    Kang, Jingjing
    Zhang, Lu
    Liang, Zhaofeng
    Tang, Xudong
    Yan, Yongmin
    Qian, Hui
    Zhang, Xu
    Xu, Wenrong
    Mao, Fei
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (03): : 881 - 891
  • [29] Role of NF-κB in immune and inflammatory responses in the gut
    Neurath, MF
    Becker, C
    Barbulescu, K
    GUT, 1998, 43 (06) : 856 - 860
  • [30] Hydroalcoholic extract of Tagetes minuta L. inhibits inflammatory bowel disease through the activity of pheophytins on the NF-κB signalling pathway
    Apaza Ticona, Luis
    Ilieva Lacheva, Ginka
    Serban, Andreea Madalina
    Rumbero Sanchez, Angel
    JOURNAL OF ETHNOPHARMACOLOGY, 2021, 268